CD8A and COVID-19: To better understand the different immune signatures of COVID-19 patients, we devised a 14-parameter flow cytometry strategy to stratify patients in terms of innate immune cell composition, lymphocyte populations, activated/exhausted CD4+ and CD8+ T cells, and B cells/plasmablasts, following a methodology adapted from reported work (14, 16, 19).